• DOI:10.1111/j.1532-5415.1976.tb03256.x
Corpus ID: 26040280

Tolmetin Sodium, a New Anti‐Arthritis Drug: Double‐Blind and Long‐Term Studies

@article{Cordrey1976TolmetinSA,
  title={Tolmetin Sodium, a New Anti‐Arthritis Drug: Double‐Blind and Long‐Term Studies},
  author={L. Cordrey},
  journal={Journal of the American Geriatrics Society},
  year={1976},
  volume={24}
}

• L. Cordrey
• Published 1976
• Medicine
• Journal of the American Geriatrics Society

ABSTRACT: The effectiveness of tolmetin sodium in the treatment of rheumatoid arthritis was evaluated by: 1) a 12‐week, double‐blind study with a dosage range of 800–1600 mg daily; and 2) an open 2‐year study with a dosage range of 400–2400 mg daily. The double‐blind study involved 14 patients (7 tolmetin sodium, 7 placebo), and the long‐term study involved 24 patients. At frequent intervals, evaluations were made of joint pain, swelling, stiffness and inflammation; grip strength; walking time… Expand

View on Wiley

ncbi.nlm.nih.gov

Save to Library

Create Alert

Cite

Launch Research Feed